These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

412 related items for PubMed ID: 24157723

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Circulating miR-125b as a biomarker of Alzheimer's disease.
    Tan L, Yu JT, Liu QY, Tan MS, Zhang W, Hu N, Wang YL, Sun L, Jiang T, Tan L.
    J Neurol Sci; 2014 Jan 15; 336(1-2):52-6. PubMed ID: 24139697
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Plasma Proteomic Profiles of Cerebrospinal Fluid-Defined Alzheimer's Disease Pathology in Older Adults.
    Dayon L, Wojcik J, Núñez Galindo A, Corthésy J, Cominetti O, Oikonomidi A, Henry H, Migliavacca E, Bowman GL, Popp J.
    J Alzheimers Dis; 2017 Jan 15; 60(4):1641-1652. PubMed ID: 29125490
    [Abstract] [Full Text] [Related]

  • 11. [Molecular markers of Alzheimer disease early diagnostic: investigation perspectives of peripheral tissues.].
    Paltsev MA, Zuev VA, Kozhevnikova EO, Linkova NS, Kvetnaia TV, Polyakova VO, Kvetnoy IM.
    Adv Gerontol; 2017 Jan 15; 30(6):809-817. PubMed ID: 29608821
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Proteomic analysis of cerebrospinal fluid in Alzheimer's disease: wanted dead or alive.
    Oláh Z, Kálmán J, Tóth ME, Zvara Á, Sántha M, Ivitz E, Janka Z, Pákáski M.
    J Alzheimers Dis; 2015 Jan 15; 44(4):1303-12. PubMed ID: 25428253
    [Abstract] [Full Text] [Related]

  • 15. Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer's disease.
    Wang MJ, Yi S, Han JY, Park SY, Jang JW, Chun IK, Kim SE, Lee BS, Kim GJ, Yu JS, Lim K, Kang SM, Park YH, Youn YC, An SSA, Kim S.
    Alzheimers Res Ther; 2017 Dec 15; 9(1):98. PubMed ID: 29246249
    [Abstract] [Full Text] [Related]

  • 16. Plasma Aβ42/40 Ratio Detects Early Stages of Alzheimer's Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study.
    Pérez-Grijalba V, Romero J, Pesini P, Sarasa L, Monleón I, San-José I, Arbizu J, Martínez-Lage P, Munuera J, Ruiz A, Tárraga L, Boada M, Sarasa M.
    J Prev Alzheimers Dis; 2019 Dec 15; 6(1):34-41. PubMed ID: 30569084
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA in Alzheimer's disease: an exploratory study in brain, cerebrospinal fluid and plasma.
    Bekris LM, Lutz F, Montine TJ, Yu CE, Tsuang D, Peskind ER, Leverenz JB.
    Biomarkers; 2013 Aug 15; 18(5):455-66. PubMed ID: 23822153
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer's Disease.
    Niemantsverdriet E, Goossens J, Struyfs H, Martin JJ, Goeman J, De Deyn PP, Vanderstichele H, Engelborghs S.
    J Alzheimers Dis; 2016 Aug 15; 51(1):97-106. PubMed ID: 26836187
    [Abstract] [Full Text] [Related]

  • 19. CSF microRNA Profiling in Alzheimer's Disease: a Screening and Validation Study.
    Dangla-Valls A, Molinuevo JL, Altirriba J, Sánchez-Valle R, Alcolea D, Fortea J, Rami L, Balasa M, Muñoz-García C, Ezquerra M, Fernández-Santiago R, Lleó A, Lladó A, Antonell A.
    Mol Neurobiol; 2017 Nov 15; 54(9):6647-6654. PubMed ID: 27738874
    [Abstract] [Full Text] [Related]

  • 20. Specific serum and CSF microRNA profiles distinguish sporadic behavioural variant of frontotemporal dementia compared with Alzheimer patients and cognitively healthy controls.
    Denk J, Oberhauser F, Kornhuber J, Wiltfang J, Fassbender K, Schroeter ML, Volk AE, Diehl-Schmid J, Prudlo J, Danek A, Landwehrmeyer B, Lauer M, Otto M, Jahn H, FTLDc study group.
    PLoS One; 2018 Nov 15; 13(5):e0197329. PubMed ID: 29746584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.